Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
MASH Rec CARD (13)
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

1479 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 64
Phase II Narcolepsy Clinical Trial Halted After Severe Adverse Effects

Phase II Narcolepsy Clinical Trial Halted After Severe Adverse Effects

According to a story from Clinical Trials Arena, the pharmaceutical company Takeda recently released findings from its phase II clinical trial. This trial was evaluating the company's investigational drug TAK-994…

Continue Reading Phase II Narcolepsy Clinical Trial Halted After Severe Adverse Effects
DAXXIFY Now FDA-Approved for the Treatment of Cervical Dystonia

DAXXIFY Now FDA-Approved for the Treatment of Cervical Dystonia

  In 2022, the U.S. Food and Drug Administration (FDA) approved DAXXIFY® (DaxibotulinumtoxinA-lanm) for the temporary treatment of fine lines and wrinkles. Many people touted DAXXIFY as a "Botox alternative."…

Continue Reading DAXXIFY Now FDA-Approved for the Treatment of Cervical Dystonia
Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies

Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies

  In a late July 2023 news release, global healthcare company Grifols shared that positive topline data was now available from a Phase 4 clinical study evaluating XEMBIFY (immune globulin…

Continue Reading Positive Data Available from Phase 4 Trial for Primary Immunodeficiencies
Can We Leverage Fecal Transplants to Improve Melanoma Outcomes?

Can We Leverage Fecal Transplants to Improve Melanoma Outcomes?

It’s no secret that our gut health plays a formative role in our overall health. Over the past decade, more and more studies have examined how the gut microbiome impacts…

Continue Reading Can We Leverage Fecal Transplants to Improve Melanoma Outcomes?
Positive Topline Data Available on VYVGART Hytrulo for People Living with CIDP

Positive Topline Data Available on VYVGART Hytrulo for People Living with CIDP

  In June 2023, the U.S. Food and Drug Administration (FDA) approved the use of VYVGART Hytrulo for people living with generalized myasthenia gravis (gMG), a chronic autoimmune neuromuscular disease…

Continue Reading Positive Topline Data Available on VYVGART Hytrulo for People Living with CIDP
ICYMI: Opfolda for Pompe Disease Now Approved in the European Union

ICYMI: Opfolda for Pompe Disease Now Approved in the European Union

  In March 2023, the European Commission (EC) approved Pombiliti (cipaglucosidase alfa) for the treatment of adult patients living with late-onset Pompe disease. Just three months later in June, another…

Continue Reading ICYMI: Opfolda for Pompe Disease Now Approved in the European Union
Certain Antibiotics Associated with Higher GvHD Risk Following Allo-HCT

Certain Antibiotics Associated with Higher GvHD Risk Following Allo-HCT

  Following allogeneic hematopoietic stem cell transplant (allo-HCT), which uses healthy stem cells from a donor, many doctors prescribe antibiotics to patients as a protective measure. Many individuals become neutropenic…

Continue Reading Certain Antibiotics Associated with Higher GvHD Risk Following Allo-HCT
Pyemotes Ventricosus Dermatitis: A Rare Condition Caused by Mites in Furniture

Pyemotes Ventricosus Dermatitis: A Rare Condition Caused by Mites in Furniture

According to a story from International Business Times, a French couple encountered an unpleasant skin condition as a result of a pest infestation in their home. Their case was reported…

Continue Reading Pyemotes Ventricosus Dermatitis: A Rare Condition Caused by Mites in Furniture
  • Go to the previous page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 185
  • Go to the next page
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info